FEMPRO 2.5 MG 10 TABLETS | Letrozole Aromatase Inhibitor
Hormonal Therapy for Hormone-Sensitive Breast Cancer
FEMPRO 2.5 MG TABLETS contain Letrozole 2.5 mg, a prescription aromatase inhibitor belonging to the class of hormonal anticancer medicines. It is primarily used for the management of hormone receptor-positive breast cancer in postmenopausal women.
Letrozole works by reducing estrogen production in the body. Since certain breast cancer cells require estrogen signals for growth, lowering estrogen levels may help slow the progression of hormone-sensitive cancer cells.
Prescription Status: Prescription-only medicine. Use only under the supervision of an oncologist or qualified healthcare professional.
Key Benefits of FEMPRO 2.5 MG TABLETS
Helps manage hormone receptor-positive breast cancer.
Reduces estrogen production by inhibiting aromatase enzyme activity.
Supports adjuvant and advanced breast cancer treatment plans when prescribed.
Helps reduce hormonal stimulation of estrogen-sensitive cancer cells.
Provides targeted hormonal therapy for eligible postmenopausal patients.
How FEMPRO 2.5 MG Works
FEMPRO contains Letrozole, which blocks the activity of the aromatase enzyme.
Aromatase normally converts androgens into estrogen in body tissues. By inhibiting this enzyme:
Estrogen production decreases.
Hormonal stimulation of estrogen receptor-positive breast cancer cells is reduced.
Growth signals dependent on estrogen may be limited.
Usage Instructions
Usually taken once daily, with or without food.
Swallow the tablet whole with water.
Take the medicine at the same time each day.
Do not stop treatment without medical advice.
Medicinal Advantages
Hormone Receptor-Positive Breast Cancer Management
FEMPRO helps reduce estrogen levels, which may support treatment of estrogen-dependent breast cancer in suitable patients.
Postmenopausal Cancer Therapy
Letrozole is commonly used in postmenopausal women for:
Early-stage hormone receptor-positive breast cancer.
Extended adjuvant therapy after initial treatment.
Advanced hormone-sensitive breast cancer.
Targeted Hormonal Action
Unlike conventional cytotoxic chemotherapy, Letrozole works by modifying hormone pathways involved in cancer cell growth.
Mechanism of Action
Letrozole selectively inhibits aromatase, an enzyme responsible for estrogen synthesis after menopause.
Reduced estrogen levels decrease activation of estrogen receptors on hormone-sensitive breast cancer cells, helping control disease progression as part of a complete cancer treatment plan.
Off-Label Uses
Letrozole may be prescribed by specialists for certain fertility-related conditions, such as ovulation induction, based on individual medical evaluation.
Off-label use should only be considered under healthcare supervision.
Expert Advice
Inform your doctor about bone health issues, liver disease, or high cholesterol.
Report persistent joint pain, unusual bone pain, or fractures.
Maintain a healthy lifestyle and follow recommended monitoring plans.
Precautions
Bone Health
Long-term estrogen reduction may affect bone mineral density. Your doctor may recommend bone health monitoring.
Pregnancy
FEMPRO should not be used during pregnancy unless specifically advised by a specialist.
Menopausal Status
Letrozole therapy is mainly used for postmenopausal women in breast cancer treatment.
Storage Instructions
Store at room temperature.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is FEMPRO 2.5 MG used for?
A: FEMPRO 2.5 MG contains Letrozole and is used for the treatment of hormone receptor-positive breast cancer, especially in postmenopausal women.
Q: What is the active ingredient in FEMPRO?
A: Each tablet contains Letrozole 2.5 mg.
Q: Is FEMPRO a chemotherapy medicine?
A: No. FEMPRO is a hormonal anticancer medicine that works by reducing estrogen production.
Q: Does FEMPRO cure breast cancer?
A: FEMPRO helps manage hormone-sensitive breast cancer as part of a comprehensive treatment plan. Individual outcomes depend on disease stage and overall therapy.
